Cancer news

The latest news in cancer research, health and policy by Cancer Research UK.

We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy. 


Personalised cancer vaccine may hold leukaemia at bay for longer

A cancer vaccine personalised to individual patients could reduce the chances of a type of blood cancer from returning, a small US study has found.

Reprogrammed immune cells fight advanced leukaemia

A specialised therapy that uses a patient’s own genetically altered cells could be an effective treatment for advanced leukaemia.

DNA sequence of cancer patient decoded for first time

Scientists at the University of Washington have sequenced the genome of a 50-year-old woman with acute myelogenous leukaemia (AML).

Drug's 'double hit' overcomes leukaemia resistance

A drug that uses a unique ‘double hit’ to kill leukaemia cells could be a potential new treatment for patients with acute myeloid leukaemia. The research, majority funded...

Aggressive leukaemia puts healthy stem cells to sleep

An aggressive form of leukaemia actually puts healthy stem cells in the bone marrow to sleep, rather than replacing them with cancer cells.

More than 33,000 childhood cancer survivors living in the UK

An estimated 33,000 long-term survivors of childhood cancer - the vast majority of whom are cured - will be living in the UK by the end of 2012.

Potential treatment for acute myeloid leukaemia identified

Scientists from the United States have identified a protein that affects the development of acute myeloid leukaemia (AML) and found that an experimental drug blocks its...

Trial launched into testosterone replacement for male cancer survivors

Cancer Research UK is today launching a trial to see if male cancer survivors could benefit from hormone replacement therapy (HRT) with testosterone.

Study shows that mutation can cause leukaemia

Scientists have found proof for the first time that a particular mutation found in some patients with acute myeloid leukaemia is linked to the disease.

Smart drug improves survival in older patients with acute myeloid leukaemia

Acute Myeloid Leukaemia (AML) patients given a new type of 'smart drug' in addition to chemotherapy treatment are 22 per cent less likely to relapse and around 13 per cent...